Our laboratory is interested in the basic mechanisms of arrhythmias, tissue engineering, and stem cell based cardiovascular repair. Our studies pointed to the initial stages of ectopic beat formation, uncovered the adverse cardiac effects of plasticizers, anti-arrhythmogenic effects of stem cells grafts and novel ways to visualize necrotic tissue in vivo. Our multidisciplinary team includes physiologists, immunologists, engineers and molecular biologists. Read more about our lab and our projects .
The National Institute of Health ranked our R21 application at 5% (expected to be funded in the Fall of 2014). The grant will allow us to examine different designs of cardiac muscle cuffs (aka minihearts) for their efficiency, including minihearts made from human cardiomyocytes derived from stem cell sources.
The American Heart Association awarded our lab with $154K grant (MidAtlantic Affiliate, Grant-In-Aid). It will enable us to create cardiac muscle cuffs (aka, minihearts) and test effect of their implantation around veins of live rats.
The George Washington University's Office of Technology Transfer (OTT) promotes new tissue engineering innovation from our laboratory.
We designed a new organ that can help to return blood flow from veins lacking functioning valves. It is a rhythmic cuff made of cardiac muscle cells that surrounds the vein. Read more
Allied Minds and The George Washington University partner to form LuxCath LLC. The George Washington University (GW) and Allied Minds, Inc., a premier U.S. investment firm, announce the formation of LuxCath LLC, a medical technology company that is developing real-time lesion visualization technology based on breakthrough research from our laboratory.
Narine Sarvazyan, Ph.D.,
The George Washington University School of Medicine and Health Sciences
2300 Eye Street NW, Washington DC 20037
Phone 202-994-0626, Fax 202-994-2870
Email: email@example.com, firstname.lastname@example.org
We are located in Ross Hall, Rooms 453-457 (Foggy Bottom Metro).